|Articles|April 9, 2023
- Pharmaceutical Executive: April 2023
- Volume 43
- Issue 4
Pharmaceutical Executive, April 2023 Issue (PDF)
Click the title above for a link to open the Pharmaceutical Executive April 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 3 years ago
Unwavering Focusover 3 years ago
A Brand Game-Changer? TikTok and Pharma Marketingover 3 years ago
Does the Biotech Sector Have Reason to Be Optimistic?over 3 years ago
Kudos and Hurdles for Industry, FDA in Tackling Rare Diseasesover 3 years ago
The Payer Value Deficit in Orphan Drugsover 3 years ago
Seizing On Asia’s Opportune Market for Novel VaccinesAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5

